SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Focused Visit (Care-plan review) — Leonardo da Vinci

PatientLeonardo da Vinci
Date of birth1961-04-24
IdentifiersMRN HR-RE001-SYN; SSN (made up) 000-01-5297
Document date2026-10-20
AuthorBeatrice Carrow-Asante, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Nine-week review of the ulnar neuropathy and lipids; decision about surgery. [S]

History of Present Illness

Mr. da Vinci returns nine weeks after the diagnosis, about fifteen weeks after the fall. He has worn both splints faithfully and has had fourteen sessions of hand therapy. The numbness of the little finger is much less. His grip is a little stronger, but the ring and little fingers still curl when he reaches for a brush, and he still cannot hold the palette in his right hand for more than a few minutes; fine brushwork with the right hand is beyond him. He draws, writes, and teaches every day with his left hand and paints small panels with a palette fixed to the easel and built-up brushes, with an assistant mixing colors. He takes atorvastatin each evening without muscle aches. He has had no further falls. [S]

ElementDetail
Splints and therapyBoth splints worn; fourteen hand-therapy sessions
SymptomsNumbness much less; grip slightly stronger; clawing persists
FunctionDrawing, writing, and teaching with the left hand; painting small panels with adapted tools
StatinNine weeks; no muscle aches

Review of Systems

SystemResultFinding
NeurologicalPositiveLittle-finger numbness much improved; persistent weakness of the right hand; no new symptoms
MusculoskeletalNegativeNo muscle aches; no elbow pain
CardiovascularNegativeNo chest pain or palpitations

3 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours as needed for elbow pain, no more than 3 g a dayOne or two tablets every 6 hours as needed; no more than six tablets a dayOral route2026-08-03 to 2026-09-14completedS
Atorvastatin 20 mg oral tablet, one tablet by mouth each eveningOne tablet by mouth each eveningOral route2026-08-17activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-10-20Body height175cmS
2026-10-20Body weight73.6kgS
2026-10-20Body mass index (BMI) [Ratio]24kg/m2S
2026-10-20Systolic blood pressure124mm[Hg]S
2026-10-20Diastolic blood pressure74mm[Hg]S
2026-10-20Heart rate66/minS
2026-10-20Respiratory rate14/minS
2026-10-20Body temperature36.5CelS
2026-10-20Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-10-20Cholesterol [Mass/volume] in Serum or Plasma158mg/dL<=199 mg/dLNormalS
2026-10-20Cholesterol in HDL [Mass/volume] in Serum or Plasma51mg/dL>=40 mg/dLNormalS
2026-10-20Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation82mg/dL<=129 mg/dLNormalS
2026-10-20Triglyceride [Mass/volume] in Serum or Plasma124mg/dL<=149 mg/dLNormalS

Physical Exam

Vital signs recorded on 2026-10-20; see the Vital Signs section. [S]

SystemFinding
Right handTwo-point discrimination 6 mm at the little finger; first dorsal interosseous 3+/5, abductor digiti minimi 4-/5, deep flexor of the little finger 4+/5; Froment sign still positive; clawing of the ring and little fingers persists; first web wasting unchanged
Right elbowTinel sign weaker; elbow flexion test positive at 45 seconds; nerve does not sublux
CardiovascularBlood pressure 124/74 mmHg; regular pulse

Problems

ProblemClinical statusVerificationCodeProvenance
Weakness, numbness of the ring and little fingers, and curling of those fingers in the right hand for four weeks after a fall onto the right elbow, in a left-handed artist who uses the right hand for the palette and brushwork; stroke and a peripheral nerve lesion under evaluationresolvedconfirmed R29.818S — Synthetic presenting concern; it echoes, without asserting, the paralysis of his right hand recorded later in 1517 (CLM-0006). Superseded by the diagnosis at the second visit.
One fall in the past year (slipped on stone stairs and landed on the right elbow), with no loss of consciousness, dizziness, or palpitations before it; fall riskactiveconfirmed Z91.81S — Synthetic fall that anchors the modern ulnar nerve injury; no historical fall is asserted.
Ulnar neuropathy at the right elbow (cubital tunnel), post-traumatic, moderately severe: sensory loss in the ulnar fingers and dorsal ulnar hand, weakness and early wasting of the intrinsic hand muscles with clawing of the ring and little fingers, focal slowing and partial conduction block across the elbow, and active denervation on EMG; stroke, C8 radiculopathy, and lower trunk plexopathy excludedactiveconfirmed G56.21S — Synthetic modern diagnosis. The paralysis of his right hand in 1517 is documented (D); its cause is unknown, and ulnar palsy, stroke, and median nerve palsy are competing retrospective readings (R).
Primary hypercholesterolemia (LDL 146 mg/dL) with a Pooled Cohort Equations 10-year ASCVD risk of 13.5 percent (PREVENT 6.9 percent); found on the stroke risk screenactiveconfirmed E78.00S — Synthetic risk factor found on the stroke risk screen; no historical lipid disorder is asserted.
Acute viral conjunctivitis, both eyes, after exposure to a student with red eyes; vision normal; resolvedresolvedconfirmed B30.9S — Synthetic intercurrent illness at an unscheduled visit; no historical eye disease is asserted.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationUlnar motor and sensory examination: strength of the first dorsal interosseous, abductor digiti minimi, and deep flexor of the little finger (MRC grade), two-point discrimination of the little finger, Froment and Wartenberg signs, clawing, and wastingEvery visit during treatmentCompleted todayTwo-point discrimination 6 mm at the little finger; first dorsal interosseous 3+/5, abductor digiti minimi 4-/5, deep flexor 4+/5; clawing persists
ExaminationGrip and key-pinch dynamometry, both handsEvery visit during treatmentCompleted todayGrip 24 kg right, 38 kg left; key pinch 3.8 kg right
SurveyPatient-reported hand function (QuickDASH)Before treatment, then at each reviewCompleted today41 of 100, from 52
Self-managementSplint use and avoiding pressure on and prolonged bending of the elbowEvery visit during treatmentCompleted todayBoth splints worn; elbow pad in use
ReferralHand therapyTwice a week from diagnosisCompleted todayFourteen sessions; continues until surgery
ReferralSurgical review at about three months for persistent weaknessAt about three months from the injuryCompleted todayDecompression chosen and booked
Medication safetyCorticosteroid injection at the cubital tunnelNot part of treatmentNot indicatedNo benefit over placebo at three months in the Cochrane review
LaboratoryLipid panel after starting a statin4 to 12 weeks after starting or changingCompleted todayLDL 82 mg/dL, 44 percent below baseline; total cholesterol 158, HDL 51, triglycerides 124 mg/dL
LaboratoryALT on a statinBaseline only; then if symptomsNot indicatedNormal at baseline; no symptoms
Medication safetyStatin adherence and muscle symptomsEvery visitCompleted todayNo missed doses; no muscle aches
ExaminationBlood pressure, weight, and smoking statusEvery visitCompleted today124/74 mmHg; 73.6 kg; never smoker

Goal progress:

Guideline basis: Cubital Tunnel Syndrome (Ulnar Nerve Entrapment at the Elbow), OrthoInfo (2026); Treatment for ulnar neuropathy at the elbow (Caliandro P, et al.) (2025); Practice parameter for electrodiagnostic studies in ulnar neuropathy at the elbow: summary statement (American Association of Electrodiagnostic Medicine, American Academy of Neurology, American Academy of Physical Medicine and Rehabilitation) (1999); 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol (2018); CMID: Clinical Monitoring Intelligence Database, hyperlipidemia monograph (2026)

Follow-up: Surgery in three weeks; post-operative review with the hand surgeon at two weeks and primary care review after that; lipid panel in a year. [S]